Global Radiopharmaceuticals Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	166 Pages	TechNavio	May, 2024	INF18851119

Best Price Guarantee
Price	from $2,500
Length	166 Pages
Publisher	TechNavio
Published Date	May, 2024
SKU	INF18851119

Global Radiopharmaceuticals Market 2024-2028

The radiopharmaceuticals market is forecasted to grow by USD 6280.6 mn during 2023-2028, accelerating at a CAGR of 12.17% during the forecast period. The report on the radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of neurological disorders, growing cancer cases rising investment in the oncology market, and minimal side effects of radiopharmaceuticals.

Technavio's radiopharmaceuticals market is segmented as below:

BySource

Cyclotrons
Nuclear reactors

ByEnd-user

Diagnostics
Therapeutics

ByGeography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the production of cyclotron-based radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, the discovery and development of new radiopharmaceuticals and improvement in healthcare infrastructure in emerging economies will lead to sizable demand in the market.

The report on the radiopharmaceuticals market covers the following areas:

Radiopharmaceuticals market sizing
Radiopharmaceuticals market forecast
Radiopharmaceuticals market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, General Electric Co., IBA Radiopharma Solutions, Jubilant Pharmova Ltd., Lantheus Holdings Inc., Mallinckrodt Plc, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Sotera Health Co., and Telix Pharmaceuticals Ltd. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Source; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Radiopharmaceuticals Market 2018 - 2022; Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2018 - 2022 ($ million); 4.2 Source segment analysis 2018 - 2022; Historic Market Size - Source Segment 2018 - 2022 ($ million); 4.3 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Source: 6.1 Market segments; Chart on Source - Market share 2023-2028 (%); Data Table on Source - Market share 2023-2028 (%); 6.2 Comparison by Source; Chart on Comparison by Source; Data Table on Comparison by Source; 6.3 Cyclotrons - Market size and forecast 2023-2028; Chart on Cyclotrons - Market size and forecast 2023-2028 ($ million); Data Table on Cyclotrons - Market size and forecast 2023-2028 ($ million); Chart on Cyclotrons - Year-over-year growth 2023-2028 (%); Data Table on Cyclotrons - Year-over-year growth 2023-2028 (%); 6.4 Nuclear reactors - Market size and forecast 2023-2028; Chart on Nuclear reactors - Market size and forecast 2023-2028 ($ million); Data Table on Nuclear reactors - Market size and forecast 2023-2028 ($ million); Chart on Nuclear reactors - Year-over-year growth 2023-2028 (%); Data Table on Nuclear reactors - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Source; Market opportunity by Source ($ million); Data Table on Market opportunity by Source ($ million)
7 Market Segmentation by End-user: 7.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 7.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 7.3 Diagnostics - Market size and forecast 2023-2028; Chart on Diagnostics - Market size and forecast 2023-2028 ($ million); Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million); Chart on Diagnostics - Year-over-year growth 2023-2028 (%); Data Table on Diagnostics - Year-over-year growth 2023-2028 (%); 7.4 Therapeutics - Market size and forecast 2023-2028; Chart on Therapeutics - Market size and forecast 2023-2028 ($ million); Data Table on Therapeutics - Market size and forecast 2023-2028 ($ million); Chart on Therapeutics - Year-over-year growth 2023-2028 (%); Data Table on Therapeutics - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.4 Bracco Spa; Bracco Spa - Overview; Bracco Spa - Product / Service; Bracco Spa - Key offerings; 12.5 Cardinal Health Inc.; Cardinal Health Inc. - Overview; Cardinal Health Inc. - Business segments; Cardinal Health Inc. - Key news; Cardinal Health Inc. - Key offerings; Cardinal Health Inc. - Segment focus; 12.6 Curium Pharma; Curium Pharma - Overview; Curium Pharma - Product / Service; Curium Pharma - Key offerings; 12.7 Eckert and Ziegler AG; Eckert and Ziegler AG - Overview; Eckert and Ziegler AG - Business segments; Eckert and Ziegler AG - Key news; Eckert and Ziegler AG - Key offerings; Eckert and Ziegler AG - Segment focus; 12.8 General Electric Co.; General Electric Co. - Overview; General Electric Co. - Business segments; General Electric Co. - Key news; General Electric Co. - Key offerings; General Electric Co. - Segment focus; 12.9 IBA Radiopharma Solutions; IBA Radiopharma Solutions - Overview; IBA Radiopharma Solutions - Business segments; IBA Radiopharma Solutions - Key news; IBA Radiopharma Solutions - Key offerings; IBA Radiopharma Solutions - Segment focus; 12.10 Jubilant Pharmova Ltd.; Jubilant Pharmova Ltd. - Overview; Jubilant Pharmova Ltd. - Business segments; Jubilant Pharmova Ltd. - Key offerings; Jubilant Pharmova Ltd. - Segment focus; 12.11 Lantheus Holdings Inc.; Lantheus Holdings Inc. - Overview; Lantheus Holdings Inc. - Business segments; Lantheus Holdings Inc. - Key offerings; Lantheus Holdings Inc. - Segment focus; 12.12 NorthStar Medical Radioisotopes LLC; NorthStar Medical Radioisotopes LLC - Overview; NorthStar Medical Radioisotopes LLC - Product / Service; NorthStar Medical Radioisotopes LLC - Key offerings; 12.13 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.14 NTP Radioisotopes SOC Ltd.; NTP Radioisotopes SOC Ltd. - Overview; NTP Radioisotopes SOC Ltd. - Product / Service; NTP Radioisotopes SOC Ltd. - Key offerings; 12.15 PharmaLogic Holdings Corp.; PharmaLogic Holdings Corp. - Overview; PharmaLogic Holdings Corp. - Product / Service; PharmaLogic Holdings Corp. - Key offerings; 12.16 Siemens AG; Siemens AG - Overview; Siemens AG - Business segments; Siemens AG - Key news; Siemens AG - Key offerings; Siemens AG - Segment focus; 12.17 Sotera Health Co.; Sotera Health Co. - Overview; Sotera Health Co. - Business segments; Sotera Health Co. - Key offerings; Sotera Health Co. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Source; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Source Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Source - Market share 2023-2028 (%); Exhibits33: Data Table on Source - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Source; Exhibits35: Data Table on Comparison by Source; Exhibits36: Chart on Cyclotrons - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Cyclotrons - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Cyclotrons - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Cyclotrons - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Nuclear reactors - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Nuclear reactors - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Nuclear reactors - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Nuclear reactors - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Source ($ million); Exhibits45: Data Table on Market opportunity by Source ($ million); Exhibits46: Chart on End-user - Market share 2023-2028 (%); Exhibits47: Data Table on End-user - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by End-user; Exhibits49: Data Table on Comparison by End-user; Exhibits50: Chart on Diagnostics - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Diagnostics - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Diagnostics - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Therapeutics - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Therapeutics - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Therapeutics - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Therapeutics - Year-over-year growth 2023-2028 (%); Exhibits58: Market opportunity by End-user ($ million); Exhibits59: Data Table on Market opportunity by End-user ($ million); Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits63: Chart on Geographic comparison; Exhibits64: Data Table on Geographic comparison; Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits101: Market opportunity By Geographical Landscape ($ million); Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits103: Impact of drivers and challenges in 2023 and 2028; Exhibits104: Overview on criticality of inputs and factors of differentiation; Exhibits105: Overview on factors of disruption; Exhibits106: Impact of key risks on business; Exhibits107: Companies covered; Exhibits108: Matrix on companies position and classification; Exhibits109: Bayer AG - Overview; Exhibits110: Bayer AG - Business segments; Exhibits111: Bayer AG - Key news; Exhibits112: Bayer AG - Key offerings; Exhibits113: Bayer AG - Segment focus; Exhibits114: Bracco Spa - Overview; Exhibits115: Bracco Spa - Product / Service; Exhibits116: Bracco Spa - Key offerings; Exhibits117: Cardinal Health Inc. - Overview; Exhibits118: Cardinal Health Inc. - Business segments; Exhibits119: Cardinal Health Inc. - Key news; Exhibits120: Cardinal Health Inc. - Key offerings; Exhibits121: Cardinal Health Inc. - Segment focus; Exhibits122: Curium Pharma - Overview; Exhibits123: Curium Pharma - Product / Service; Exhibits124: Curium Pharma - Key offerings; Exhibits125: Eckert and Ziegler AG - Overview; Exhibits126: Eckert and Ziegler AG - Business segments; Exhibits127: Eckert and Ziegler AG - Key news; Exhibits128: Eckert and Ziegler AG - Key offerings; Exhibits129: Eckert and Ziegler AG - Segment focus; Exhibits130: General Electric Co. - Overview; Exhibits131: General Electric Co. - Business segments; Exhibits132: General Electric Co. - Key news; Exhibits133: General Electric Co. - Key offerings; Exhibits134: General Electric Co. - Segment focus; Exhibits135: IBA Radiopharma Solutions - Overview; Exhibits136: IBA Radiopharma Solutions - Business segments; Exhibits137: IBA Radiopharma Solutions - Key news; Exhibits138: IBA Radiopharma Solutions - Key offerings; Exhibits139: IBA Radiopharma Solutions - Segment focus; Exhibits140: Jubilant Pharmova Ltd. - Overview; Exhibits141: Jubilant Pharmova Ltd. - Business segments; Exhibits142: Jubilant Pharmova Ltd. - Key offerings; Exhibits143: Jubilant Pharmova Ltd. - Segment focus; Exhibits144: Lantheus Holdings Inc. - Overview; Exhibits145: Lantheus Holdings Inc. - Business segments; Exhibits146: Lantheus Holdings Inc. - Key offerings; Exhibits147: Lantheus Holdings Inc. - Segment focus; Exhibits148: NorthStar Medical Radioisotopes LLC - Overview; Exhibits149: NorthStar Medical Radioisotopes LLC - Product / Service; Exhibits150: NorthStar Medical Radioisotopes LLC - Key offerings; Exhibits151: Novartis AG - Overview; Exhibits152: Novartis AG - Business segments; Exhibits153: Novartis AG - Key news; Exhibits154: Novartis AG - Key offerings; Exhibits155: Novartis AG - Segment focus; Exhibits156: NTP Radioisotopes SOC Ltd. - Overview; Exhibits157: NTP Radioisotopes SOC Ltd. - Product / Service; Exhibits158: NTP Radioisotopes SOC Ltd. - Key offerings; Exhibits159: PharmaLogic Holdings Corp. - Overview; Exhibits160: PharmaLogic Holdings Corp. - Product / Service; Exhibits161: PharmaLogic Holdings Corp. - Key offerings; Exhibits162: Siemens AG - Overview; Exhibits163: Siemens AG - Business segments; Exhibits164: Siemens AG - Key news; Exhibits165: Siemens AG - Key offerings; Exhibits166: Siemens AG - Segment focus; Exhibits167: Sotera Health Co. - Overview; Exhibits168: Sotera Health Co. - Business segments; Exhibits169: Sotera Health Co. - Key offerings; Exhibits170: Sotera Health Co. - Segment focus; Exhibits171: Inclusions checklist; Exhibits172: Exclusions checklist; Exhibits173: Currency conversion rates for US$; Exhibits174: Research methodology; Exhibits175: Information sources; Exhibits176: Data validation; Exhibits177: Validation techniques employed for market sizing; Exhibits178: Data synthesis; Exhibits179: 360 degree market analysis; Exhibits180: List of abbreviations